Financial statements Pharmexpert
Balance sheet data of PHARMEXPERT
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 657 555,23 | 686 499,24 | 678 281,10 | 640 000,42 | 631 527,51 | 675 400,66 |
| A. Fixed assets | 114 996,69 | 118 697,80 | 110 323,46 | 111 313,12 | 104 809,45 | 100 176,47 |
| B. Current assets | 542 558,54 | 567 801,44 | 567 957,64 | 528 687,30 | 526 718,06 | 575 224,19 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 657 555,23 | 686 499,24 | 678 281,10 | 640 000,42 | 631 527,51 | 675 400,66 |
| A. Equity | -880 021,26 | -966 801,14 | -1 151 348,28 | -1 257 625,88 | -1 403 864,56 | -1 606 915,27 |
| B. Liabilities and provisions for liabilities | 1 537 576,49 | 1 653 300,38 | 1 829 629,38 | 1 897 626,30 | 2 035 392,07 | 2 282 315,93 |
| I. Long-term liabilities | 857 223,89 | 884 188,86 | 944 439,48 | 1 062 079,47 | 1 151 355,47 | 1 217 628,00 |
| II. Short-term liabilities | 663 430,30 | 755 658,14 | 698 041,59 | 824 152,65 | 880 867,38 | 1 047 985,60 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.